July 2020 BRI Research Update: Profiling the Course of COVID-19

Originally presented to donors in appreciation for their support, three leading researchers at Benaroya Research Institute at Virginia Mason (BRI) shared updates on BRI’s research into predicting COVID-19 interventions and outcomes. President Jane Buckner, MD, explains BRI’s rapid response to COVID-19; Director of the Center for Fundamental Immunology Daniel Campbell, PhD, explores immune signatures of COVID-19 recovery; and Associate Member Erik Wambre, PhD, illustrates how his team is visualizing immunity to COVID-19. BRI is a world-renowned, non-profit medical research institute committed to advancing the science that will predict, prevent, reverse and cure diseases of the immune system. To learn more about our COVID-19 research, visit BRI’s Autoimmune Life blog.